Skip to content

Post-Endoscopic Infection Rate Notifications to Improve the Delivery of Care

Post-Endoscopic Infection Rate Notifications to Improve the Delivery of Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03922971
Enrollment
303
Registered
2019-04-22
Start date
2019-08-07
Completion date
2023-06-15
Last updated
2023-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

colonoscopy, EGD, endoscopy, ASC, outpatient, infection, Endoscopic procedures

Brief summary

This project will notify centers of center's post-endoscopic infection rates and evaluate the effectiveness of this notification system to decrease infection rates. The investigators aim to notify centers of the number of patients and center's risk-adjusted rates of hospitalizations for infections after colonoscopy and esophagogastroduodenoscopy (EGD) procedures performed between January 2015 and September 2018. The investigators will randomize centers to two notification groups: (1) Ability to view center's rate compared with all other centers (ASCs and outpatient centers notified and compared separately) or (2) Ability to view center's rate compared with the other centers with a similar patient comorbidity profile and in addition to viewing option 1. Facilities will answer questions about center's infection control practices. The investigators hypothesize that centers with high rates of post-procedural infections will (1) be more likely to report that the center took action to investigate the center's infection control practices after the first notification and (2) observe a decrease in infections after the notification. The investigators anticipate that centers with high rates of post-procedural infections that are randomized to group 2 will have greater change. The investigators anticipate no change in rates of infection in the facilities that had zero or very low (n=1) event rates.

Interventions

OTHEROption 1: National comparison

Ability to view center's rate compared with all others.

OTHEROption 2: National comparison with benchmarking

Ability to view center's rate compared with the others with a similar patient comorbidity profile and in addition to viewing option 1.

Sponsors

Medivators Cantel
CollaboratorUNKNOWN
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Facilities that bill to fee for service Medicare for gastrointestinal endoscopy

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Change in the infection rate among centers with elevated infection ratesBaseline, 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026